These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6459954)

  • 1. Streptozotocin induced diabetic nephropathy and renal tumors in the rat.
    Bleasel AF; Yong LC
    Experientia; 1982 Jan; 38(1):129-30. PubMed ID: 6459954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological changes in streptozotocin induced diabetes mellitus in the rat.
    Yong LC; Bleasel AF
    Exp Pathol; 1986; 30(2):97-107. PubMed ID: 3780940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy.
    Falk RJ; Scheinman JI; Mauer SM; Michael AF
    Diabetes; 1983 May; 32 Suppl 2():34-9. PubMed ID: 6400667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.
    Li Z; Zhang H; Dong X; Burczynski FJ; Choy P; Yang F; Liu H; Li P; Gong Y
    Biochem Cell Biol; 2010 Aug; 88(4):635-48. PubMed ID: 20651835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
    Huang H; Jiang Y; Mao G; Yuan F; Zheng H; Ruan Y; Wu T
    J Sci Food Agric; 2017 Mar; 97(4):1359-1366. PubMed ID: 27363537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kidney in streptozotocin diabetic rats. Morphologic, ultrastructural, and function studies.
    Weil R; Nozawa M; Koss M; Weber C; Reemtsma K; McIntosh R
    Arch Pathol Lab Med; 1976 Jan; 100(1):37-49. PubMed ID: 130091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney.
    Grove KJ; Lareau NM; Voziyan PA; Zeng F; Harris RC; Hudson BG; Caprioli RM
    Kidney Int; 2018 Aug; 94(2):292-302. PubMed ID: 29779708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of glomerular basement membrane components in Vacor-induced diabetic nephropathy.
    Seon YD; Lee TH; Lee MC
    Korean J Intern Med; 1999 Jan; 14(1):77-84. PubMed ID: 10063318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased concentration of albumin in kidney basement membranes in diabetes mellitus.
    Michael AF; Brown DM
    Diabetes; 1981 Oct; 30(10):843-6. PubMed ID: 7274588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 2u-globulin nephropathy and carcinogenicity following exposure to decalin (decahydronaphthalene) in F344/N rats.
    Dill JA; Lee KM; Renne RA; Miller RA; Fuciarelli AF; Gideon KM; Chan PC; Burka LT; Roycroft JH
    Toxicol Sci; 2003 Apr; 72(2):223-34. PubMed ID: 12660359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of nicotinamide against nephropathy in diabetic rats.
    Wahlberg G; Carlson LA; Wasserman J; Ljungqvist A
    Diabetes Res; 1985 Nov; 2(6):307-12. PubMed ID: 2934204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione status, lipid peroxidation and kidney function in streptozotocin diabetic rats.
    Bräunlich H; Marx F; Stein G
    Exp Toxicol Pathol; 1994 Jul; 46(2):143-7. PubMed ID: 7987072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats.
    Morsy MA; Heeba GH; Mahmoud ME
    Eur J Pharmacol; 2015 Mar; 750():90-7. PubMed ID: 25625658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephropathy in a hypercholesterolemic mouse model with streptozotocin-induced diabetes.
    Hammad SM; Hazen-Martin DJ; Sohn M; Eldridge L; Powell-Braxton L; Won W; Lyons TJ
    Kidney Blood Press Res; 2003; 26(5-6):351-61. PubMed ID: 14610340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural changes in the renal vasculature in streptozotocin-induced diabetic rats without hypertension.
    Turoni CM; Reynoso HA; Marañón RO; Coviello A; Peral de Bruno M
    Nephron Physiol; 2005; 99(2):p50-7. PubMed ID: 15637426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal microvascular changes in streptozotocin-induced, long-termed diabetic rat.
    Sricharoenvej S; Tongpob Y; Lanlua P; Piyawinijwong S; Roongruangchai J; Phoungpetchara I
    J Med Assoc Thai; 2007 Dec; 90(12):2677-82. PubMed ID: 18386720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats.
    Nicholas SB; Mauer M; Basgen JM; Aguiniga E; Chon Y
    Am J Nephrol; 2004; 24(5):549-56. PubMed ID: 15539791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Dec; (557):1-163. PubMed ID: 21415873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic transplantation in diabetic rats: renal function, morphology, ultrastructure, and immunohistology.
    Weil R; Nozawa M; Koss M; Weber C; Reemtsma K; McIntosh RM
    Surgery; 1975 Aug; 78(2):142-8. PubMed ID: 125459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.